Is MicroStrategy Still a “Bitcoin Bank”? MicroStrategy, the business intelligence firm led by Michael Saylor, made waves in the financial world when it announced its pivot to Bitcoin in 2020. Since then, the company has been known as a “Bitcoin bank” due to its significant holdings of the digital currency. However, with the recent rebranding…
Enhanced Caller ID for AT&T Wireless Customers Introduction AT&T wireless customers can now enjoy a new feature that provides enhanced Caller ID information on verified incoming calls. This feature allows users to see the companies’ names, logos, and reasons for calls directly on their Android devices, without the need for any additional apps. How It…
Growing Together: A Look Back at GrowGeneration Corp.’s Success in 2024 Dear Fellow Shareholders, Denver—(BUSINESS WIRE)—GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGen” or the “Company”), one of the largest retailers and distributors of specialty hydroponic and organic gardening products in the United States, today issued the following letter to shareholders commenting on the Company’s 2024 accomplishments, preliminary…
Allarity Therapeutics Announces Phase 2 Clinical Development Plans for Stenoparib in Ovarian Cancer Boston (February 6, 2025) Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR) is a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated dual PARP/Wnt pathway inhibitor—as a personalized cancer treatment using its proprietary, drug-specific patient selection technology—the Drug Response…
Welcome to the CAMP4 Therapeutics Corporation Blog! Exciting News from CAMP4! Hey there, fellow science enthusiasts! Have you heard the latest news from CAMP4 Therapeutics Corporation? Well, hold onto your lab coats because we’ve got some truly groundbreaking updates to share with you! Just recently, on February 6, 2025, CAMP4 announced some major developments that…
Brensocatib: A Game-Changer in Bronchiectasis Treatment The Breakthrough in Bronchiectasis Treatment Insmed Incorporated has recently made a groundbreaking announcement that could potentially revolutionize the treatment of bronchiectasis. Brensocatib, if approved by the FDA, would be the first and only available treatment for this condition. This drug, which is the first of its kind as a…
Opawica Explorations Inc. Engages RJLL Forage Drilling for Bazooka Property February 6th, 2024 – Vancouver, B.C. – TheNewswire Introduction Opawica Explorations Inc. (TSXV:OPW) (FSE:A2PEAD) (OTC:OPWEF), a leading exploration company, has recently announced its partnership with RJLL Forage Drilling (“RJLL”) of Rouyn-Noranda, QC. The collaboration aims to conduct drilling activities on the Bazooka Property located in…
Welcome to the Future of Cancer Treatment A New Era in RNA Oncology Breaking News: Cohort 3 of TransCode Therapeutics’ Phase 1 Clinical Trial Hey there, fellow health enthusiasts! Today we’re diving into some groundbreaking news in the world of oncology. TransCode Therapeutics, Inc. has just announced some promising updates on their Phase 1 clinical…
